UCB Competitors and Similar CompaniesClear all

UCB's competitors and similar companies include Jazz Pharmaceuticals, Lundbeck, Amarin and Genewiz.
UCB
UCB
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
Jazz Pharmaceuticals
Jazz Pharmaceuticals
Jazz Pharmaceuticals is an international biopharmaceutical company.
Lundbeck
Lundbeck
H. Lundbeck is a pharmaceutical company specializing in brain diseases.
Amarin
Amarin
Amarin Corporation is a pharmaceutical company that engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases.
Genewiz
Genewiz
GENEWIZ specializes in DNA services, including DNA sequencing, gene synthesis, molecular biology, genomic, and regulatory services.
Founding Date
Founding Date
1928
Founding Date
2003
Founding Date
1915
Founding Date
1991
Founding Date
1999
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Brussels, BE HQ
Melbourne, AU
Vienna, AT
Braine L'alleud, BE
Braine L'alleud, BE
Leuven, BE
São Paulo, BR
see more
Locations
Dublin, IE HQ
Mississauga, CA
Vancouver, CA
Lyon, FR
München, DE
Roscommon, IE
Villa Guardia, IT
see more
Locations
København, DK HQ
Buenos Aires, AR
North Ryde, AU
Wien, AT
Bruxelles, BE
Rio De Janeiro, BR
Sofia, BG
see more
Locations
Dublin, IE HQ
Zug, CH
Bridgewater Township, US
Locations
South Plainfield, US HQ
Guangzhou Shi, CN
Suzhou Shi, CN
Paris, FR
see more
Employees
Employees
9,0521% increase
Employees
2,800
Employees
5,7072% decrease
Employees
275
Employees
139
Valuation ($)
Valuation ($)
34.3 b
Valuation ($)
6.9 b
Valuation ($)
6.2 b
Valuation ($)
257.6 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
€5.6b (FY, 2024)
Revenue (est.)
$4.1b (FY, 2024)
Revenue (est.)
kr22b (FY, 2024)
Revenue (est.)
$228.6m (FY, 2024)
Revenue (est.)
N/A
Cost of goods
Cost of goods
€1.1b (FY, 2024)
Cost of goods
N/A
Cost of goods
kr2.5b (FY, 2024)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
€6.2b (FY, 2024)
Gross profit
N/A
Gross profit
kr19.5b (FY, 2024)
Gross profit
$81.4m (FY, 2024)
Gross profit
N/A
Net income
Net income
€1.1b (FY, 2024)
Net income
$560.1m (FY, 2024)
Net income
kr3.1b (FY, 2024)
Net income
($82.2m) (FY, 2024)
Net income
N/A

Operating

Countries
Countries
35 (FY, 2019)
Countries
N/A
Countries
100 (May, 2024)
Countries
N/A
Countries
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 384.1m
Total funding raised
N/A
Total funding raised
$ 122.8m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Jazz Pharmaceuticals
HQ
Dublin, IE
Employees
2,800

Jazz Pharmaceuticals is an international biopharmaceutical company.

View company
Lundbeck
HQ
København, DK
Employees
5,707↓ 2% decrease

H. Lundbeck is a pharmaceutical company specializing in brain diseases.

View company
Amarin
HQ
Dublin, IE
Employees
275

Amarin Corporation is a pharmaceutical company that engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases.

View company
Genewiz
HQ
South Plainfield, US
Employees
139

GENEWIZ specializes in DNA services, including DNA sequencing, gene synthesis, molecular biology, genomic, and regulatory services.

View company